REQUEST A DEMO
Total
USD $0.00
Search more companies

Dallas Drugs Private Limited (India)

Main Activities: All Other Food Manufacturing
Full name: Dallas Drugs Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dallas Drugs Private Limited is an unlisted company, incorporated on 25/04/2012. It has its registered office in the State of Chandigarh, India. Company's corporate identification number (CIN) is U15400CH2012PTC033748 and registration number is 033748. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Headquarters
Sco No. 805 1St Floor (Half Portion At 1St Floor) N.A.C Manimajra Chandigarh In-Ch In 160002
Chandigarh; Punjab; Postal Code: 160002

Contact Details: Purchase the Dallas Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Dallas Drugs Private Limited report to view the information.
Outstanding Shares:
Purchase the Dallas Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Dallas Drugs Private Limited report to view the information.
Incorporation Date:
April 25, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Dallas Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-18.68%
Total operating revenue
-18.72%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-11.1%
Total equity
17.34%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-985.38%
Quick Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?